We are live on ! Find out more
ETM

Euclidean Technologies Management Portfolio holdings

AUM $109M
1-Year Est. Return 7.18%
This Fund
S&P 500
This Quarter Est. Return
-6.9%
1 Year Est. Return
+7.18%
3 Year Est. Return
+123.73%
5 Year Est. Return
+76.06%
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$11.3M
Cap. Flow
-$2.11M
Cap. Flow %
-1.95%
Top 10 Hldgs %
22.24%
Holding
102
New
12
Increased
13
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
IIIN icon
Insteel Industries
IIIN
+$2.01M
2
CVLG icon
Covenant Logistics
CVLG
+$1.98M
3
TITN icon
Titan Machinery
TITN
+$964K
4
HIBB
Hibbett, Inc. Common Stock
HIBB
+$921K
5
REX icon
REX American Resources
REX
+$911K

Top Sells

Rank Stock Value
1
RMAX icon
RE/MAX Holdings
RMAX
+$1.7M
2
CBT icon
Cabot Corp
CBT
+$1.52M
3
PLUS icon
ePlus
PLUS
+$1.35M
4
VIVO
Meridian Bioscience Inc
VIVO
+$1.06M
5
DXPE icon
DXP Enterprises
DXPE
+$968K

Sector Composition

Rank Sector Weight
1 Industrials 39.13%
2 Consumer Discretionary 23.98%
3 Consumer Staples 14.98%
4 Technology 9.9%
5 Healthcare 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HMTV
51
DELISTED
Hemisphere Media Group, Inc.
HMTV
$678K 0.63%
148,292
-30,900
-17% -$186K
DXPE icon
52
DXP Enterprises
DXPE
$2.6B
$514K 0.47%
18,964
-34,119
-64% -$968K
ATKR icon
53
Atkore
ATKR
$2.48B
$497K 0.46%
5,050
– –
IDT icon
54
IDT Corp
IDT
$1.57B
$341K 0.32%
10,008
– –
ABBV icon
55
AbbVie
ABBV
$450B
$336K 0.31%
2,071
– –
COR icon
56
Cencora
COR
$59.9B
$281K 0.26%
1,814
– –
BCC icon
57
Boise Cascade
BCC
$2.72B
$276K 0.26%
3,976
– –
HPQ icon
58
HP
HPQ
$22.7B
$276K 0.26%
7,608
– –
STRL icon
59
Sterling Infrastructure
STRL
$19.6B
$259K 0.24%
9,650
– –
MCK icon
60
McKesson
MCK
$98.5B
$258K 0.24%
842
– –
RVTY icon
61
Revvity
RVTY
$12.3B
$257K 0.24%
1,475
– –
INVA icon
62
Innoviva
INVA
$1.6B
$252K 0.23%
13,005
– –
MLI icon
63
Mueller Industries
MLI
$13.1B
$252K 0.23%
18,604
– –
TSN icon
64
Tyson Foods
TSN
$20.3B
$249K 0.23%
2,775
– –
IPG
65
DELISTED
Interpublic Group of Companies
IPG
$239K 0.22%
6,750
– –
IRWD icon
66
Ironwood Pharmaceuticals
IRWD
$635M
$232K 0.21%
18,475
– –
CARS icon
67
Cars.com
CARS
$670M
$227K 0.21%
15,725
– –
LH icon
68
Labcorp
LH
$23.2B
$224K 0.21%
988
– –
COLL icon
69
Collegium Pharmaceutical
COLL
$1.17B
$222K 0.21%
10,900
– –
TGNA
70
DELISTED
TEGNA Inc
TGNA
$218K 0.2%
+9,712
New +$204K
QDEL icon
71
QuidelOrtho
QDEL
$1.19B
$217K 0.2%
1,932
– –
BMY icon
72
Bristol-Myers Squibb
BMY
$124B
$215K 0.2%
+2,945
New +$198K
MRNA icon
73
Moderna
MRNA
$24.5B
$215K 0.2%
+1,246
New +$210K
EME icon
74
Emcor
EME
$33.1B
$211K 0.19%
1,870
– –
HOLX
75
DELISTED
Hologic
HOLX
$210K 0.19%
2,740
– –
1 2
3
4 5

Similar funds

CWM
Catalyst Wealth Management Atlanta, Georgia $107M AUM
ACM
Acrisure Capital Management Austin, Texas $98.8M AUM
RA
Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return
AMC
Asset Management Corp Northbrook, Illinois $128M AUM 6.72% 1-Year Est. Return
BCM
Brainard Capital Management Austin, Texas $131M AUM
HLCM
Hickory Lane Capital Management New York $81.7M AUM 4.68% 1-Year Est. Return
TWP
Transparent Wealth Partners Little Rock, Arkansas $137M AUM 7.32% 1-Year Est. Return
PCM
Praetorian Capital Management Coral Gables, Florida $137M AUM

Euclidean Technologies Management's Q1 2022 Portfolio in Review

As of Q1 2022, Euclidean Technologies Management held 102 positions worth $108M, down 9.4% from $120M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Euclidean Technologies Management's Q1 2022 filing shows 12 new, 13 increased, 14 reduced and 19 closed positions. Its largest new stake was Insteel Industries: 51,906 shares worth $1.92M. The largest sale was RE/MAX Holdings, an estimated $1.7M.

By sector, the portfolio is most concentrated in Industrials at 39% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Euclidean Technologies Management's largest Q1 2022 buy was Insteel Industries: 51,906 shares worth $1.92M.
  • Euclidean Technologies Management added most to Hibbett, Inc. Common Stock in Q1 2022, an estimated $921K increase.
  • Euclidean Technologies Management's biggest Q1 2022 reduction was Meridian Bioscience Inc, cutting an estimated $1.06M.
  • Euclidean Technologies Management fully exited RE/MAX Holdings in Q1 2022, selling an estimated $1.7M.
  • Euclidean Technologies Management's ten largest holdings make up 22% of its $108M portfolio in Q1 2022.
  • Euclidean Technologies Management opened 12 new positions and closed 19 in Q1 2022.
  • Euclidean Technologies Management's portfolio value fell 9.4% quarter-over-quarter to $108M.

Based on Euclidean Technologies Management's 13F filing for Q1 2022, filed 28 Apr 2022.